Clinical Trials Logo

Asthma, Exercise-Induced clinical trials

View clinical trials related to Asthma, Exercise-Induced.

Filter by:

NCT ID: NCT00664937 Completed - Clinical trials for Asthma, Exercise-induced

Exercise Induced Bronchoconstriction (0476-359)

Start date: May 2007
Phase: Phase 1
Study type: Interventional

Exercise-induced bronchoconstriction (EIB) is a condition where airways tighten when you exercise and may cause coughing, wheezing, or shortness of breath. In many patients, this condition can cause lung function to drop making it harder to breath. An instrument called a spirometer is commonly used to measure lung function. This traditional means of assessing lung function in asthma is limited in its ability to provide information as to where in the lung the tightness is. Hyperpolarized helium magnetic resonance imaging (3He MRI) is a novel way to see the where air is going in the lungs using an MRI and special gas. The ability to see where the air can and cannot reach in the lungs may help show more accurately if a medication is working to make the asthma better. The purpose of this study is to examine patients with EIB in order to see if 3He MRI provides a better way to measure lung function. Patients will be given either montelukast sodium, a drug to improve the ability to breath with EIB, or placebo and then put on a treadmill to induce an occurrence of airway constriction. The patient's lung function will be measured more than once using both the spirometer and the 3He MRI.

NCT ID: NCT00322283 Completed - Clinical trials for Exercise-Induced Asthma

Study of Oglemilast for the Prevention of Asthma.

Start date: May 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether it is effective in the treatment of exercise-induced asthma and investigate the safety of oglemilast.

NCT ID: NCT00273689 Completed - Clinical trials for Exercise Induced Bronchospasm

Exercise Induced Bronchospasm in Children

Start date: December 2005
Phase: Phase 4
Study type: Interventional

The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine is better at stopping asthma symptoms caused by exercising.

NCT ID: NCT00268723 Completed - Clinical trials for Exercise-induced Bronchospasm

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Start date: December 2005
Phase: Phase 3
Study type: Interventional

To determine if administration of levalbuterol tartrate HFA MDI in subjects with EIB will be effective in the prevention of EIB and be safe and well-tolerated.

NCT ID: NCT00245570 Completed - Clinical trials for Asthma, Exercise-Induced

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

Start date: December 2005
Phase: Phase 3
Study type: Interventional

To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.

NCT ID: NCT00127166 Completed - Clinical trials for Exercise Induced Asthma

Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)

Start date: December 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effect of four weeks of treatment with two investigational drugs (oral versus inhaled administration) plus an inhaled medication in the treatment of airway constriction brought on by exercise in participants with asthma.

NCT ID: NCT00118716 Completed - Bronchospasm Clinical Trials

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

Start date: December 23, 2003
Phase: Phase 4
Study type: Interventional

During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history review, exercise challenge test (walking/running on a treadmill), electrocardiogram (ECG) tests, and lung function tests. All study related medications and medical examinations are provided at no cost. All study drugs are currently available by prescription to patients 4 years and older.

NCT ID: NCT00118690 Completed - Bronchospasm Clinical Trials

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

Start date: December 2003
Phase: Phase 4
Study type: Interventional

During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history review, exercise challenge test (walking/running on a treadmill), electrocardiogram (ECG) tests, and lung function tests. All study related medications and medical examinations are provided at no cost. All study drugs are currently available by prescription to patients 4 years and older.

NCT ID: NCT00092131 Completed - Clinical trials for Asthma, Exercise-Induced

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

Start date: June 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.

NCT ID: NCT00090142 Completed - Clinical trials for Asthma, Exercise-Induced

Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)

Start date: May 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.